NCI SBIR Development Center Revenue and Competitors
Estimated Revenue & Valuation
- NCI SBIR Development Center's estimated annual revenue is currently $3.4M per year.
- NCI SBIR Development Center's estimated revenue per employee is $155,000
Employee Data
- NCI SBIR Development Center has 22 Employees.
- NCI SBIR Development Center grew their employee count by 5% last year.
NCI SBIR Development Center's People
Name | Title | Email/Phone |
---|
NCI SBIR Development Center Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.3M | 2 | -60% | N/A | N/A |
#2 | $2.9M | 38 | -31% | $17.5M | N/A |
#3 | $2.9M | 38 | -33% | $10.5M | N/A |
#4 | $19.8M | 128 | 0% | $69.4M | N/A |
#5 | $9.6M | 62 | -15% | N/A | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $2.5M | 16 | 0% | N/A | N/A |
#8 | $7.4M | 48 | 0% | N/A | N/A |
#9 | $0.2M | 1 | -83% | N/A | N/A |
#10 | $1.7M | 11 | 22% | N/A | N/A |
What Is NCI SBIR Development Center?
NCI leads, conducts, and supports the cancer research across the nation to advance scientific knowledge and help all people live longer, healthier lives. The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs are NCI's engine of innovation for developing and commercializing novel technologies and products to prevent, diagnose, and treat cancer. The SBIR & STTR Programs are one of the largest sources of early-stage technology financing in the United States. We welcome entrepreneurs and small business leaders to this website to explore grant and contract funding opportunities and a new spirit of collaboration with the NCI.
keywords:N/AN/A
Total Funding
22
Number of Employees
$3.4M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $5.1M | 22 | -15% | N/A |
#2 | $2.2M | 22 | 5% | N/A |
#3 | $2.2M | 22 | -4% | N/A |
#4 | $4.2M | 22 | -29% | N/A |
#5 | $2.3M | 23 | N/A | N/A |